Release Date: 24/10/17 17:27 Summary: Stratex Update - Shareholder Meeting Price Sensitive: No Download Document 155.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%